.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Triamcinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for triamcinolone acetonide?

Triamcinolone acetonide is the generic ingredient in twenty-four branded drugs marketed by Mylan Pharms Inc, Apothecon, Delcor Asset Corp, Taro, Parnell, Perrigo Israel, Ranbaxy Labs Ltd, Teligent Pharma Inc, Teva, Pharmafair, Akorn, Solvay, Perrigo New York, Alpharma Us Pharms, Astellas, Abbvie, Glenmark Pharms Ltd, Allergan, Lupin Atlantis, Watson Labs, Ivax Pharms, G And W Labs Inc, Ambix, Crown Labs, Novartis Pharms Corp, Wockhardt Eu Operatn, Wockhardt, Sandoz Canada Inc, Sandoz, Fougera Pharms, Sanofi Aventis Us, Vintage, Lyne, Topiderm, Perrigo Uk Finco, Pharmaderm, Morton Grove, Savage Labs, G And W Labs, Carolina Medcl, and Actavis Mid Atlantic, and is included in one hundred and seventeen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has fifty-six patent family members in thirty-two countries.

There are forty-nine drug master file entries for triamcinolone acetonide. Seventy-nine suppliers are listed for this compound.

Summary for Generic Name: triamcinolone acetonide

Tradenames:24
Patents:7
Applicants:41
NDAs:117
Drug Master File Entries: see list49
Suppliers / Packagers: see list79
Bulk Api Vendors: see list49
Clinical Trials: see list113
Patent Applications: see list6,040
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:triamcinolone acetonide at DailyMed

Pharmacology for Ingredient: triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
TRIACET
triamcinolone acetonide
CREAM;TOPICAL084908-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
CREAM;TOPICAL088818-001Oct 16, 1984DISCNNoNo► Subscribe► Subscribe
Akorn
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
PASTE;DENTAL206312-001Aug 11, 2016RXNoNo► Subscribe► Subscribe
Vintage
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL040671-002Jun 9, 2006RXNoNo► Subscribe► Subscribe
Morton Grove
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
OINTMENT;TOPICAL088092-001Sep 1, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
AZMACORT
triamcinolone acetonide
AEROSOL, METERED;INHALATION018117-001Apr 23, 19823,897,779► Subscribe
Sanofi Aventis Us
NASACORT
triamcinolone acetonide
AEROSOL, METERED;NASAL019798-001Jul 11, 19914,767,612► Subscribe
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 20137,977,045► Subscribe
Abbvie
AZMACORT
triamcinolone acetonide
AEROSOL, METERED;INHALATION018117-001Apr 23, 19823,927,806► Subscribe
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 20136,143,329► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: triamcinolone acetonide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,375,984 Aqueous-based pharmaceutical composition► Subscribe
7,122,206Aqueous-based pharmaceutical composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: triamcinolone acetonide

Country Document Number Estimated Expiration
China1235568► Subscribe
South Korea20000023563► Subscribe
Denmark0938345► Subscribe
Hungary227993► Subscribe
Canada2268927► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc